Market Overview:
The global metabolomics market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth of the market can be attributed to the increasing demand for personalized medicine, rising prevalence of chronic diseases, and growing application areas of metabolomics. Based on type, the global metabolomics market is segmented into separation techniques, detection techniques, and others. The separation techniques segment is further divided into chromatography techniques and electrophoresis techniques. The detectiontechniques segment is further divided into spectroscopy methods and mass spectrometry methods. Others include data analysis software and services. Based on application, the global metabolomics market is classified into drug assessment, biomarker discovery, nutrigenomics,, clinical toxicology,, pharmacogenetics,, environmental toxicology,, forensic toxicology,.and others (tissue engineering etc.). Geographically,.the global metabolomicmarketis analyzedinto North America,.Latin America,.Europe., Asia Pacific.,and Middle East & Africa. Some of the major players in this market are Thermo Fisher Scientific Inc., Agilent Technologies Inc.
Product Definition:
Metabolomics is the study of the metabolome, which is the complete set of small-molecule metabolites present in a biological sample. The metabolome represents the state of all biochemical pathways in a cell or tissue and can be used to detect changes in metabolism associated with disease or other physiological conditions.
Separation Techniques:
The global market for metabolomics is expected to witness significant growth over the forecast period. The key driver of this market is technological advancement in analytical separation techniques coupled with growing demand for personalized medicine.
Metabolomics helps understand disease progression and develop a treatment plan by analyzing biological samples, which includes urine, blood, hair, skin cells or swabs from patients themselves.
Detection Techniques:
Detection techniques are the most important step in metabolomics study as it provides quantification of metabolites and helps to understand their role in disease. There are different detection techniques available like liquid chromatography, mass spectrometry, infrared & nuclear magnetic resonance spectroscopy etc. which can be used according to the requirement.
Application Insights:
The drug assessment segment dominated the global market in 2017. The key factors contributing to this growth include an increase in number of clinical trials and adoption of metabolomics for discovering novel biomarkers associated with adverse effects of drugs. For instance, a study carried out by researchers from the National Cancer Center, Japan, aimed at detecting tumor-specific biomarkers using high-throughput metabolite profiling techniques. This research was supported by the Japan Society for the Promotion of Science (JSPS) and Metabolon Inc.¢â‚¬â„¢s ¢â‚¬Å“Drug Discovery Platform¢â‚¬ was designed to screen large sets of patients' urine samples against several cancer drugs at once to identify those that are likely to have fewer side effects and may be more effective than other existing treatments.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of research organizations and universities involved in metabolomics studies, increasing funding for metabolomics-based research, and growing adoption of NGS platforms by researchers. Moreover, an increase in R&D activities related to nutrigenomics and biomarkers is expected to fuel regional growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising investments by governments as well as private entities for improving healthcare facilities across countries such as India, China, Japan, Singapore & Australia (Icasa). In addition it will boost demand for nutritional products due growing population along with rapid urbanization & changing lifestyle habits which are likely fueling demand for dietary supplements leading into future years.
Growth Factors:
- Increasing demand for personalized medicines
- Rising prevalence of chronic diseases
- Technological advancements in metabolomics platforms and analytical techniques
- Growing public and private investments in metabolomics research
- Expansion of metabolomics services and applications into new markets
Scope Of The Report
Report Attributes
Report Details
Report Title
Metabolomics Market Research Report
By Type
Separation Techniques, Detection Techniques, Others
By Application
Drug Assessment, Biomarker Discovery, Nutrigenomics, Clinical toxicology, Others
By Companies
Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Biocrates Life Sciences AG, Shimadzu Corporation, Waters Corporation, Human Metabolome Technologies, Inc., LECO Corporation, Metabolon, Inc., Bio-Rad Laboratories, Inc., Bruker Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
209
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global Metabolomics Market Report Segments:
The global Metabolomics market is segmented on the basis of:
Types
Separation Techniques, Detection Techniques, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug Assessment, Biomarker Discovery, Nutrigenomics, Clinical toxicology, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- Biocrates Life Sciences AG
- Shimadzu Corporation
- Waters Corporation
- Human Metabolome Technologies, Inc.
- LECO Corporation
- Metabolon, Inc.
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
Highlights of The Metabolomics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Separation Techniques
- Detection Techniques
- Others
- By Application:
- Drug Assessment
- Biomarker Discovery
- Nutrigenomics
- Clinical toxicology
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Metabolomics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Metabolomics is the study of the chemical reactions that take place in cells and tissues. This information can be used to help identify problems with metabolism, and to develop new treatments for diseases.
Some of the major players in the metabolomics market are Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Biocrates Life Sciences AG, Shimadzu Corporation, Waters Corporation, Human Metabolome Technologies, Inc., LECO Corporation, Metabolon, Inc., Bio-Rad Laboratories, Inc., Bruker Corporation.
The metabolomics market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Metabolomics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Metabolomics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Metabolomics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Metabolomics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Metabolomics Market Size & Forecast, 2018-2028
4.5.1 Metabolomics Market Size and Y-o-Y Growth
4.5.2 Metabolomics Market Absolute $ Opportunity
Chapter 5 Global Metabolomics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Metabolomics Market Size Forecast by Type
5.2.1 Separation Techniques
5.2.2 Detection Techniques
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Metabolomics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Metabolomics Market Size Forecast by Applications
6.2.1 Drug Assessment
6.2.2 Biomarker Discovery
6.2.3 Nutrigenomics
6.2.4 Clinical toxicology
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Metabolomics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Metabolomics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Metabolomics Analysis and Forecast
9.1 Introduction
9.2 North America Metabolomics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Metabolomics Market Size Forecast by Type
9.6.1 Separation Techniques
9.6.2 Detection Techniques
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Metabolomics Market Size Forecast by Applications
9.10.1 Drug Assessment
9.10.2 Biomarker Discovery
9.10.3 Nutrigenomics
9.10.4 Clinical toxicology
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Metabolomics Analysis and Forecast
10.1 Introduction
10.2 Europe Metabolomics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Metabolomics Market Size Forecast by Type
10.6.1 Separation Techniques
10.6.2 Detection Techniques
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Metabolomics Market Size Forecast by Applications
10.10.1 Drug Assessment
10.10.2 Biomarker Discovery
10.10.3 Nutrigenomics
10.10.4 Clinical toxicology
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Metabolomics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Metabolomics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Metabolomics Market Size Forecast by Type
11.6.1 Separation Techniques
11.6.2 Detection Techniques
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Metabolomics Market Size Forecast by Applications
11.10.1 Drug Assessment
11.10.2 Biomarker Discovery
11.10.3 Nutrigenomics
11.10.4 Clinical toxicology
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Metabolomics Analysis and Forecast
12.1 Introduction
12.2 Latin America Metabolomics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Metabolomics Market Size Forecast by Type
12.6.1 Separation Techniques
12.6.2 Detection Techniques
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Metabolomics Market Size Forecast by Applications
12.10.1 Drug Assessment
12.10.2 Biomarker Discovery
12.10.3 Nutrigenomics
12.10.4 Clinical toxicology
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Metabolomics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Metabolomics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Metabolomics Market Size Forecast by Type
13.6.1 Separation Techniques
13.6.2 Detection Techniques
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Metabolomics Market Size Forecast by Applications
13.10.1 Drug Assessment
13.10.2 Biomarker Discovery
13.10.3 Nutrigenomics
13.10.4 Clinical toxicology
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Metabolomics Market: Competitive Dashboard
14.2 Global Metabolomics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific, Inc.
14.3.2 Agilent Technologies, Inc.
14.3.3 Biocrates Life Sciences AG
14.3.4 Shimadzu Corporation
14.3.5 Waters Corporation
14.3.6 Human Metabolome Technologies, Inc.
14.3.7 LECO Corporation
14.3.8 Metabolon, Inc.
14.3.9 Bio-Rad Laboratories, Inc.
14.3.10 Bruker Corporation
